Private company

SomaLogic, Inc.

American commercial physical and biological research services company.

Last updated Oct 18, 2026.

Overview

  • IndustryServices-Commercial Physical & Biological Research
  • HeadquartersDE
  • Incorporated inDE2
  • Business addressC/O Somalogic, Inc., 2945 Wilderness Place, Boulder, Co 803012
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-180.0%Operating margin3
-111.8%Net margin3
19.7%Revenue growth, 20223
-19.4%Return on equity3
-$105.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Research and development32¢$73.4M
  • Selling, general and admin68¢$156.6M
  • Income tax0¢$717.0K

Out of $97.7M in revenue.3 The company lost money this year.

Financial statements

Revenue43$97.7M in 2022+75% since 2020
0$25.0M$50.0M$75.0M$100.0M2020: $55.9M$55.9M20202021: $81.6M$81.6M2021+46%2022: $97.7M$97.7M2022+20%
Operating income43-$175.8M in 2022+412% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$34.4M-$34.4M20202021: -$73.3M-$73.3M2021+113%2022: -$175.8M-$175.8M2022+140%
Net income43-$109.2M in 2022+106% since 2020
-$150.0M-$100.0M-$50.0M02020: -$53.0M-$53.0M20202021: -$87.5M-$87.5M2021+65%2022: -$109.2M-$109.2M2022+25%
Fiscal year2019202020212022
Revenue$55.9M4$81.6M3$97.7M3
Research and development$30.7M4$43.5M3$73.4M3
Selling, general and admin$36.9M4$78.0M3$156.6M3
Operating income-$34.4M4-$73.3M3-$175.8M3
Interest$18.3M4$1.3M3$03
Income tax$23.0K4$38.0K3-$717.0K3
Net income-$53.0M4-$87.5M3-$109.2M3
Earnings per share-$0.814-$0.643-$0.593
Earnings per share (diluted)-$0.814-$0.643-$0.593

Compare SomaLogic, Inc. with another company

Leadership

Who has led SomaLogic, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (18)

Former names

  • CM Life Sciences II Inc.Dec 31, 2020 to Sep 1, 20212

Timeline

  1. Apr 7, 2023New chief executive Adam Taich becomes CEO8
  2. Sep 10, 2021New chief executive Roy Smythe becomes CEO10
  3. Feb 22, 2021New chief executive Eli Casdin becomes CEO9

Filings

198 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 43 major events, 73 insider forms, 7 large holders, 66 other. The latest 20:

  1. Jan 10, 2025SCHEDULE 13G/A EDGAR
  2. Jan 29, 2024SC 13G/A EDGAR
  3. Jan 16, 202415-12G EDGAR
  4. Jan 11, 2024EFFECT EDGAR
  5. Jan 11, 2024EFFECT EDGAR
  6. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  7. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  8. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  9. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  10. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  11. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  12. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  13. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  14. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  15. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  16. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  17. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  18. Jan 9, 20244 FORM 4 SUBMISSION EDGAR
  19. Jan 9, 2024SC 13D/A EDGAR
  20. Jan 5, 2024POS AM EDGAR

The 198 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 7 such filings since October 2021:

  1. Jan 10, 2025SCHEDULE 13G/A
  2. Jan 29, 2024SC 13G/A
  3. Jan 9, 2024SC 13D/A
  4. Feb 14, 2023SC 13G/A
  5. Dec 14, 2022SC 13D/A
  6. Feb 11, 2022SC 13G
  7. Oct 8, 2021SC 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.